Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran and omeprazole in myocardial injury after noncardiac surgery
2011-006056-37Phase 3Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dabigatran and omeprazole in Myocardial injury (4 arms), sponsored by Hamilton Health Sciences. Primary endpoints: Primary outcome for dabigatran and Primary outcome for omeprazole. Started Sep 2013; status: completed.
02
Drugs
dabigatranomeprazole
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on 2011-006056-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006056-37.